» Articles » PMID: 30101279

Consensus on Shared Measures of Mobility and Cognition: From the Canadian Consortium on Neurodegeneration in Aging (CCNA)

Abstract

Background: A new paradigm is emerging in which mobility and cognitive impairments, previously studied, diagnosed, and managed separately in older adults, are in fact regulated by shared brain resources. Deterioration in these shared brain mechanisms by normal aging and neurodegeneration increases the risk of developing dementia, falls, and fractures. This new paradigm requires an integrated approach to measuring both domains. We aim to identify a complementary battery of existing tests of mobility and cognition in community-dwelling older adults that enable assessment of motor-cognitive interactions.

Methods: Experts on mobility and cognition in aging participated in a semistructured consensus based on the Delphi process. After performing a scoping review to select candidate tests, multiple rounds of consultations provided structured feedback on tests that captured shared characteristics of mobility and cognition. These tests needed to be sensitive to changes in both mobility and cognition, applicable across research studies and clinics, sensitive to interventions, feasible to perform in older adults, been previously validated, and have minimal ceiling/floor effects.

Results: From 17 tests appraised, 10 tests fulfilled prespecified criteria and were selected as part of the "Core-battery" of tests. The expert panel also recommended a "Minimum-battery" of tests that included gait speed, dual-task gait speed, the Montreal Cognitive Assessment and Trail Making Test A&B.

Conclusions: A standardized assessment battery that captures shared characteristics of mobility and cognition seen in aging and neurodegeneration may increase comparability across research studies, detection of subtle or common reversible factors, and accelerate research progress in dementia, falls, and aging-related disabilities.

Citing Articles

Mapping the neural substrate of high dual-task gait cost in older adults across the cognitive spectrum.

Ali P, Dinomais M, Labriffe M, Pieruccini-Faria F, Montero-Odasso M, Bartha R Brain Struct Funct. 2025; 230(1):25.

PMID: 39755775 PMC: 11700055. DOI: 10.1007/s00429-024-02873-6.


Clinical features of fallers and non-fallers: finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.

Hirata R, Thomsen M, Liston M, Christensen M, Vestergaard P Osteoporos Int. 2024; 35(11):2007-2016.

PMID: 39180678 PMC: 11499445. DOI: 10.1007/s00198-024-07233-y.


Perturbation-based balance training of older adults and effects on physiological, cognitive and sociopsychological factors: a secondary analysis from a randomised controlled trial with 12-month follow-up.

Norgaard J, Andersen S, Ryg J, Andreasen J, Oliveira A, Stevenson A BMJ Open. 2024; 14(8):e080550.

PMID: 39117404 PMC: 11404139. DOI: 10.1136/bmjopen-2023-080550.


Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study.

Sakurai R, Pieruccini-Faria F, Cornish B, Fraser J, Binns M, Beaton D Alzheimers Dement. 2024; 20(4):2968-2979.

PMID: 38470007 PMC: 11032526. DOI: 10.1002/alz.13740.


Performance of the walking trail making test in older adults with white matter hyperintensities.

Zhao H, Zhang Z, Huang Y, Li H, Wei F World J Psychiatry. 2024; 14(1):102-110.

PMID: 38327891 PMC: 10845218. DOI: 10.5498/wjp.v14.i1.102.


References
1.
Montero-Odasso M, Wells J, Borrie M . Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009; 57(2):359-60. PMC: 5017867. DOI: 10.1111/j.1532-5415.2009.02085.x. View

2.
Allali G, Annweiler C, Blumen H, Callisaya M, De Cock A, Kressig R . Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative. Eur J Neurol. 2015; 23(3):527-41. PMC: 4769662. DOI: 10.1111/ene.12882. View

3.
Montero-Odasso M, Muir-Hunter S, Oteng-Amoako A, Gopaul K, Islam A, Borrie M . Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial. J Alzheimers Dis. 2014; 43(1):193-9. DOI: 10.3233/JAD-140759. View

4.
Montero-Odasso M, Muir S, Speechley M . Dual-task complexity affects gait in people with mild cognitive impairment: the interplay between gait variability, dual tasking, and risk of falls. Arch Phys Med Rehabil. 2012; 93(2):293-9. DOI: 10.1016/j.apmr.2011.08.026. View

5.
Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View